AIFortuneabout 2 hours ago
Insilico AI Drug Enters Phase 3 Trials in China
8 min read
Insilico Medicine's AI-discovered drug rentosertib for idiopathic pulmonary fibrosis has begun Phase 3 trials in China. The company claims it is the first AI-discovered drug to reach this stage. A study in Nature Biotechnology showed the drug may reverse biological age in some patients.
Level
Hype check
Tap to vote and see what everyone thinks.
